Combinatorial group theory: a topological approach

por Cohen, Daniel E
Publicado 1989

Groups of cohomological dimension one

por Cohen, Daniel E
Publicado 1972

Ombitasvir, paritaprevir, and ritonavir with peginterferon-α2a plus ribavirin in treatment-experienced patients with chronic hepatitis C virus genotype 1 infection

por Bernstein, David, Tripathi, Rakesh, Cohen, Daniel E
Publicado 2019

Effects of a ritonavir‐containing regimen on the pharmacokinetics of sirolimus or everolimus in healthy adult subjects

por Zha, Jiuhong, Jiang, Qi, Yao, Betty B., Cohen, Daniel E., Carter, David C., Menon, Rajeev M.
Publicado 2022

Effect of Hepatitis C Treatment with Ombitasvir/Paritaprevir/R + Dasabuvir on Renal, Cardiovascular and Metabolic Extrahepatic Manifestations: A Post-Hoc Analysis of Phase 3 Clinic...

por Mehta, Darshan A., Cohen, Eric, Charafeddine, Mariem, Cohen, Daniel E., Bao, Yanjun, Sanchez Gonzalez, Yuri, Tran, Tram T.
Publicado 2017

Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens

por Vasanthakumar, Aparna, Davis, Justin W., Abunimeh, Manal, Söderholm, Jonas, Zha, Jiuhong, Dumas, Emily O., Cohen, Daniel E., Waring, Jeffrey F., Lagging, Martin
Publicado 2018

Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disorders

por Fuchs, Michael, Monto, Alexander, Bräu, Norbert, Charafeddine, Mariem, Schmidt, Warren, Kozal, Michael, Naggie, Susanna, Cheung, Ramsey, Schnell, Gretja, Yu, Yao, Richards, Kristine, Mullally, Victoria, Cohen, Daniel E., Toro, Doris
Publicado 2020

Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney Disease

por Bernstein, David E., Tran, Albert, Martin, Paul, Kowdley, Kris V., Bourliere, Marc, Sulkowski, Mark S., Pockros, Paul J., Renjifo, Boris, Wang, Deli, Shuster, Diana L., Cohen, Daniel E., Jacobson, Ira M.
Publicado 2018

T-cell Activation Is Correlated With Monocyte Activation in HCV/HIV Coinfection and Declines During HCV Direct-Acting Antiviral Therapy

por Auma, Ann W N, Shive, Carey, Damjanovska, Sofi, Kowal, Corinne, Cohen, Daniel E, Bhattacharya, Debika, Alston-Smith, Beverly, Osborne, Melissa, Kalayjian, Robert, Balagopal, Ashwin, Sulkowski, Mark, Wyles, David, Anthony, Donald D
Publicado 2021

A Phase-I pharmacokinetic, safety and food-effect study on flubentylosin, a novel analog of Tylosin-A having potent anti-Wolbachia and antifilarial activity

por Alami, Negar, Carter, David C., Kwatra, Nisha V., Zhao, Weihan, Snodgrass, Linda, Porcalla, Ariel R., Klein, Cheri E., Cohen, Daniel E., Gallenberg, Loretta, Neenan, Melina, Carr, Robert A., Marsh, Kennan C., Kempf, Dale J.
Publicado 2023

Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients With Hepatitis C Virus Genotype 1 or 4 Infection and Advanced Kidney Disease

por Lawitz, Eric, Gane, Edward, Cohen, Eric, Vierling, John, Agarwal, Kosh, Hassanein, Tarek, Mantry, Parvez S., Pockros, Paul J., Bennett, Michael, Kemmer, Nyingi, Morelli, Giuseppe, Zha, Jiuhong, Wang, Deli, Shulman, Nancy S., Cohen, Daniel E., Reddy, K. Rajender
Publicado 2018

Parabacteroides distasonis: intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health

por Ezeji, Jessica C., Sarikonda, Daven K., Hopperton, Austin, Erkkila, Hailey L., Cohen, Daniel E., Martinez, Sandra P., Cominelli, Fabio, Kuwahara, Tomomi, Dichosa, Armand E. K., Good, Caryn E., Jacobs, Michael R., Khoretonenko, Mikhail, Veloo, Alida, Rodriguez-Palacios, Alexander
Publicado 2021

Fully Differentiated HIV-1 Specific CD8+ T Effector Cells Are More Frequently Detectable in Controlled than in Progressive HIV-1 Infection

por Addo, Marylyn M., Draenert, Rika, Rathod, Almas, Verrill, Cori L., Davis, Benjamin T., Gandhi, Rajesh T., Robbins, Gregory K., Basgoz, Nesli O., Stone, David R., Cohen, Daniel E., Johnston, Mary N., Flynn, Theresa, Wurcel, Alysse G., Rosenberg, Eric S., Altfeld, Marcus, Walker, Bruce D.
Publicado 2007

Ombitasvir/Paritaprevir/Ritonavir With or Without Dasabuvir and With or Without Ribavirin for Adolescents With HCV Genotype 1 or 4

por Leung, Daniel H., Wirth, Stefan, Yao, Betty B., Viani, Rolando M., Gonzalez‐Peralta, Regino P., Jonas, Maureen M., Lobritto, Steven J., Narkewicz, Michael R., Sokal, Etienne, Fortuny, Clàudia, Hsu, Evelyn K., Del Valle‐Segarra, Antonio, Zha, Jiuhong, Larsen, Lois, Liu, Li, Shuster, Diana L., Cohen, Daniel E., Rosenthal, Philip
Publicado 2018